Autolus Therapeutics plc

AUTL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$79-$48-$70-$28
Dep. & Amort.$1$4$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$4$3$6
Change in WC$41-$23-$18-$3
Other Non-Cash-$34-$11$7-$16
Operating Cash Flow-$68-$73-$76-$38
Investing Activities
PP&E Inv.$16-$7-$8-$11
Net Acquisitions$0$0$0$0
Inv. Purchases-$83-$48-$71$0
Inv. Sales/Matur.$131$151$20$0
Other Inv. Act.-$28$0$0-$372
Investing Cash Flow$36$96-$60-$384
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$1$0$30
Financing Cash Flow-$2-$1$0$30
Forex Effect-$4$6$4-$38
Net Chg. in Cash-$38$28-$132-$430
Supplemental Information
Beg. Cash$125$97$229$659
End Cash$88$125$97$229
Free Cash Flow-$52-$80-$84-$62